BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

Contributed by: Business Wire

Logo

Tags

Technology

Genetics

Clinical Trials

Software

Biotechnology

Health

Pharmaceutical

Data Management

Oncology

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

More Like This

BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference

BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025

BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026

BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025

BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026

BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026

BeOne Medicines' biologics manufacturing facility and clinical R&D center in Hopewell, NJ.

BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology